Scott Bizily
Förmögenhet: 87 721 $ per 2026-07-31
Förmögenhet: 87 721 $ per 2026-07-31
Dr. Scott P.
Bizily is a Secretary, Chief Compliance & Legal Officer at 4D Molecular Therapeutics, Inc. Dr. Bizily was previously employed as a General Counsel by Synthego Corp.
and a Director-Corporate Counsel by BioMarin Pharmaceutical, Inc. He received his graduate degree from the University of Pennsylvania and a doctorate degree from the University of Georgia.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-17 | 8 617 ( 0,02 % ) | 87 721 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Compliance Officer | 2021-12-01 |
| Företag | Position | Slut |
|---|---|---|
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Engages in research, development and manufactures CRISPR cell & gene therapies | Generell Rådgivare | 2021-09-01 |
| BIOMARIN PHARMACEUTICAL INC. | Generell Rådgivare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Engages in research, development and manufactures CRISPR cell & gene therapies | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån